Are Profits Driving Medical Research?

Tuesday, October 04, 2011

On April 12, 1955, Edward R. Murrow interviewed Dr. Jonas Salk on the CBS show, "See it Now." Salk’s polio vaccine had just been proven effective in preventing the disease. Murrow asked who owned the vaccine. "The people I would say," Salk answered. "There is no patent. Could you patent the sun?" Medical research culture has changed dramatically since Salk's time. Had it been invented today, it seems likely that the polio vaccine would have been patented immediately, and that Salk would have worked for a pharmaceutical company, rather than a university.

Harriet Washington writes about the consequences of profit-driven medical research in her new book, "Deadly Monopolies: The Shocking Corporate Takeover of Life Itself — And the Consequences for Your Health and Our Medical Future."

Guests:

Harriet Washington

Produced by:

Jillian Weinberger

Comments [6]

Melba04 from India

One of the most expensive and fastest growing academic research and development in the field of medical research. Institutions in different parts of the world is to spend time honing their faculties and upgrade their facilities to meet the cutting edge of what it means to give medical assistance to the public and sometimes private.

<a href="http://www.epharmacygold.com/">e-pharmacy</a>

Nov. 04 2011 02:01 AM
drivingiscool from United States

Murrow asked who owned the vaccine. For example the various statins that followed Mevacor into the market provided improved potency and demonstrated value in terms of outcomes. Names are displayed with all comments. We reserve the right to edit any comments posted on this site. Please read the Comment Guidelines before posting.I love this <a href="http://www.easterlydriving.co.uk/">driving instuctor</a>.

Oct. 28 2011 07:29 PM
drivingiscool from USA

Murrow asked who owned the vaccine. For example the various statins that followed Mevacor into the market provided improved potency and demonstrated value in terms of outcomes. Names are displayed with all comments. We reserve the right to edit any comments posted on this site. Please read the Comment Guidelines before posting.I love this <a href="http://www.easterlydriving.co.uk/">driving lesson</a>.

Oct. 28 2011 07:16 PM
drivingiscool from USA

Murrow asked who owned the vaccine. For example the various statins that followed Mevacor into the market provided improved potency and demonstrated value in terms of outcomes. Names are displayed with all comments. We reserve the right to edit any comments posted on this site. Please read the Comment Guidelines before posting.I love this <a href="http://www.easterlydriving.co.uk/">driving school</a>.

Oct. 28 2011 06:56 PM
drivingiscool from USA

Murrow asked who owned the vaccine. For example the various statins that followed Mevacor into the market provided improved potency and demonstrated value in terms of outcomes. Names are displayed with all comments. We reserve the right to edit any comments posted on this site. Please read the Comment Guidelines before posting.I love this <a href="http://www.easterlydriving.co.uk/">intensive course</a>.

Oct. 28 2011 06:38 PM
Joel Flamholz

To state that modifying an existing molecule does not provide value is somewhat simplistic. For example the various statins that followed Mevacor into the market provided improved potency and demonstrated value in terms of outcomes. You can call these "me too" drugs or the result of greed in the pharmaceutical industry, but they provided real value to the medical consumer.

Oct. 04 2011 09:55 AM

Leave a Comment

Register for your own account so you can vote on comments, save your favorites, and more. Learn more.
Please stay on topic, be civil, and be brief.
Email addresses are never displayed, but they are required to confirm your comments. Names are displayed with all comments. We reserve the right to edit any comments posted on this site. Please read the Comment Guidelines before posting. By leaving a comment, you agree to New York Public Radio's Privacy Policy and Terms Of Use.